These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36476295)

  • 1. A second case of liraglutide-type localised amyloidosis.
    Muhammad S; McPhail ED; Tobin WO; Dasari S; Theis J; Vrana JA; Naddaf E
    Amyloid; 2023 Jun; 30(2):244-245. PubMed ID: 36476295
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel iatrogenic amyloidosis caused by peptide drug liraglutide: a clinical mimic of AL amyloidosis.
    Martins CO; Lezcano C; Yi SS; Landau HJ; Chapman JR; Dogan A
    Haematologica; 2018 Dec; 103(12):e610-e612. PubMed ID: 30262557
    [No Abstract]   [Full Text] [Related]  

  • 3. Localised amyloidosis of the urinary bladder: a case report and review of treatment.
    Shittu OB; Weston PM
    West Afr J Med; 1994; 13(4):252-3. PubMed ID: 7756197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBUS-TBNA diagnosis of localised amyloidosis presenting as mediastinal lymphadenopathy.
    Kumar A; Sivasailam B; Marciniak E; Deepak J
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A rare case of localised oral amyloid of the labial mucosa.
    Folkard SS; Gibbs SD; Shah KA; Dhariwal DK
    Br J Oral Maxillofac Surg; 2014 Apr; 52(4):e24-5. PubMed ID: 24560006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liraglutide and a lipidized analog of prolactin-releasing peptide show neuroprotective effects in a mouse model of β-amyloid pathology.
    Holubová M; Hrubá L; Popelová A; Bencze M; Pražienková V; Gengler S; Kratochvílová H; Haluzík M; Železná B; Kuneš J; Hölscher C; Maletínská L
    Neuropharmacology; 2019 Jan; 144():377-387. PubMed ID: 30428311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history and outcomes in localised immunoglobulin light-chain amyloidosis: a long-term observational study.
    Mahmood S; Bridoux F; Venner CP; Sachchithanantham S; Gilbertson JA; Rowczenio D; Wagner T; Sayed R; Patel K; Fontana M; Whelan CJ; Lachmann HJ; Hawkins PN; Gillmore JD; Wechalekar AD
    Lancet Haematol; 2015 Jun; 2(6):e241-50. PubMed ID: 26688234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of primary systemic amyloidosis.
    Mirfeizi Z; Hatef MR; Hashemzadeh K; Hashemzadeh S; Tayebi N
    Int J Rheum Dis; 2012 Oct; 15(5):e134-5. PubMed ID: 23083051
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and treatment of Al amyloidosis.
    Seldin DC
    Clin Adv Hematol Oncol; 2003 Mar; 1(3):154-5. PubMed ID: 16224395
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary localised laryngeal amyloidosis.
    Bozkus F; Ulas T; Lynen I; Ozardali I; Sans I
    J Pak Med Assoc; 2013 Mar; 63(3):385-6. PubMed ID: 23914645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary localized cutaneous nodular amyloidosis successfully treated with cyclophosphamide.
    Tong PL; Walker WA; Glancy RJ; Cooney JP; Gebauer K
    Australas J Dermatol; 2013 Feb; 54(1):e12-5. PubMed ID: 23373889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of complete screening for amyloid fibril type and systemic disease in patients with amyloidosis in the respiratory tract.
    Shah PL; Gillmore JD; Copley SJ; Collins JV; Wells AU; du Bois RM; Hawkins PN; Nicholson AG
    Sarcoidosis Vasc Diffuse Lung Dis; 2002 Jun; 19(2):134-42. PubMed ID: 12102609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JCS 2020 Guideline on Diagnosis and Treatment of Cardiac Amyloidosis.
    Kitaoka H; Izumi C; Izumiya Y; Inomata T; Ueda M; Kubo T; Koyama J; Sano M; Sekijima Y; Tahara N; Tsukada N; Tsujita K; Tsutsui H; Tomita T; Amano M; Endo J; Okada A; Oda S; Takashio S; Baba Y; Misumi Y; Yazaki M; Anzai T; Ando Y; Isobe M; Kimura T; Fukuda K;
    Circ J; 2020 Aug; 84(9):1610-1671. PubMed ID: 32830187
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary systemic amyloidosis.
    Patel AL; Jayaram S; Shaikh WA; Basavaraj A; Patel H; Malaviya AP; Kabra D; Patil A; Bhende N
    J Assoc Physicians India; 2004 Apr; 52():335-7. PubMed ID: 15636344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recurrent multifocal primary amyloidosis of urinary bladder.
    Patel S; Trivedi A; Dholaria P; Dholakia M; Devra A; Gupta B; Shah SA
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):247-9. PubMed ID: 18310877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in diagnosis and treatment of cardiac amyloidosis.
    Izumiya Y; Takashio S; Oda S; Yamashita Y; Tsujita K
    J Cardiol; 2018 Feb; 71(2):135-143. PubMed ID: 29113705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Amyloidosis].
    Moszczyński P
    Pieleg Polozna; 1984; (10):16-7. PubMed ID: 6570234
    [No Abstract]   [Full Text] [Related]  

  • 19. [Primary AL-type amyloidosis disclosed by Horton disease].
    Tron AM; Piperno M; Bouvier R; Conrozier T; Vignon E
    Rev Med Interne; 1995; 16(11):850-3. PubMed ID: 8570943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of localised ureteric amyloidosis.
    Consigliere DT; Lim-Tan SK; Li MK; Foo KT
    Ann Acad Med Singap; 1994 Jan; 23(1):117-9. PubMed ID: 8185260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.